Cargando…

Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives

Intranasal delivery of DNA vaccines has become a popular research area recently. It offers some distinguished advantages over parenteral and other routes of vaccine administration. Nasal mucosa as site of vaccine administration can stimulate respiratory mucosal immunity by interacting with the nasop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yingying, Yuen, Pak-Wai, Lam, Jenny Ka-Wing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190526/ https://www.ncbi.nlm.nih.gov/pubmed/25014738 http://dx.doi.org/10.3390/pharmaceutics6030378

Ejemplares similares

Intranasal Immunization with an Archaeal Lipid Mucosal Vaccine Adjuvant and Delivery Formulation Protects against a Respiratory Pathogen Challenge
por: Patel, Girishchandra B., et al.
Publicado: (2010)

Design of a Protective Single-Dose Intranasal Nanoparticle-Based Vaccine Platform for Respiratory Infectious Diseases
por: Ulery, Bret D., et al.
Publicado: (2011)

Protection against feline infectious peritonitis by intranasal inoculation of a temperature-sensitive FIPV vaccine
por: Gerber, J.D., et al.
Publicado: (1990)

Efficacy of intranasal and spray delivery of adjuvanted live vaccine against infectious bronchitis virus in experimentally infected poultry
por: Deville, Sebastien, et al.
Publicado: (2012)

Strategies for intranasal delivery of vaccines
por: Zaman, Mehfuz, et al.
Publicado: (2012)

Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation
por: Voß, Franziska, et al.
Publicado: (2018)

Intranasal Delivery of Cationic PLGA Nano/Microparticles- Loaded FMDV DNA Vaccine Encoding IL-6 Elicited Protective Immunity against FMDV Challenge
por: Wang, Gang, et al.
Publicado: (2011)

Intranasal Delivery of Mesenchymal Stromal Cells Protects against Neonatal Hypoxic–Ischemic Brain Injury
por: McDonald, Courtney A., et al.
Publicado: (2019)

Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes
por: Rosada, Rogério S, et al.
Publicado: (2008)

Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge
por: Hooper, Jay W., et al.
Publicado: (2007)

Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant
por: Dwivedi, Varun, et al.
Publicado: (2011)

Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
por: Mao, Tianyang, et al.
Publicado: (2022)

A non-replicative antibiotic resistance-free DNA vaccine delivered by the intranasal route protects against canine leishmaniasis
por: Alonso, Ana, et al.
Publicado: (2023)

Pulmonary delivery of therapeutic siRNA
por: Lam, Jenny Ka-Wing, et al.
Publicado: (2012)

The In Ovo Delivery of CpG Oligonucleotides Protects against Infectious Bronchitis with the Recruitment of Immune Cells into the Respiratory Tract of Chickens
por: De Silva Senapathi, Upasama, et al.
Publicado: (2018)

Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application
por: Lankelma, Jacqueline M., et al.
Publicado: (2017)

Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse
por: Du, Yingying, et al.
Publicado: (2021)

Intranasal Vaccine Delivery Technology for Respiratory Tract Disease Application with a Special Emphasis on Pneumococcal Disease
por: Walkowski, William, et al.
Publicado: (2021)

A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
por: Hassan, Ahmed O., et al.
Publicado: (2020)

An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
por: Hassan, Ahmed O., et al.
Publicado: (2021)

Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID)
por: Seyfoori, Amir, et al.
Publicado: (2021)

Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases
por: Grunwald, Thomas, et al.
Publicado: (2015)

Intranasal H5N1 Vaccines, Adjuvanted with Chitosan Derivatives, Protect Ferrets against Highly Pathogenic Influenza Intranasal and Intratracheal Challenge
por: Mann, Alex J., et al.
Publicado: (2014)

Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs
por: Dhakal, Santosh, et al.
Publicado: (2018)

Intranasal HD-Ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2
por: Cao, Huibi, et al.
Publicado: (2021)

Comparative efficacy of a multi-epitope DNA vaccine via intranasal, peroral, and intramuscular delivery against lethal Toxoplasma gondii infection in mice
por: Cong, Hua, et al.
Publicado: (2014)

Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
por: Park, Jun-Gyu, et al.
Publicado: (2021)

Intranasal Delivery of Antiviral siRNA
por: Barik, Sailen
Publicado: (2010)

Engineering DNA vaccines against infectious diseases
por: Lee, Jihui, et al.
Publicado: (2018)

Gelatin nanoparticle-mediated intranasal delivery of substance P protects against 6-hydroxydopamine-induced apoptosis: an in vitro and in vivo study
por: Lu, Cui-Tao, et al.
Publicado: (2015)

Intranasal or airborne transmission-mediated delivery of an attenuated SARS-CoV-2 protects Syrian hamsters against new variants
por: Stauft, Charles B., et al.
Publicado: (2023)

Anatomical and Histological Factors Affecting Intranasal Drug and Vaccine Delivery
por: Gizurarson, Sveinbjörn
Publicado: (2012)

Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery
por: Duong, Van-An, et al.
Publicado: (2023)

Protection of chickens against infectious bronchitis virus with a multivalent DNA vaccine and boosting with an inactivated vaccine
por: Yan, Fang, et al.
Publicado: (2013)

Intranasal Delivery of a Chitosan-Hydrogel Vaccine Generates Nasal Tissue Resident Memory CD8(+) T Cells That Are Protective against Influenza Virus Infection
por: Bedford, James G., et al.
Publicado: (2020)

Intranasal Allopregnanolone Confers Rapid Seizure Protection: Evidence for Direct Nose-to-Brain Delivery
por: Zolkowska, Dorota, et al.
Publicado: (2021)

An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters
por: Deng, Shaofeng, et al.
Publicado: (2023)

Induction of cross-protection against influenza A virus by DNA prime-intranasal protein boost strategy based on nucleoprotein
por: Luo, Jian, et al.
Publicado: (2012)

Intranasal Immunization with DnaK Protein Induces Protective Mucosal Immunity against Tuberculosis in CD4-Depleted Mice
por: Chuang, Yu-Min, et al.
Publicado: (2018)

Advances in vaccine delivery systems against viral infectious diseases
por: Kim, Dongyoon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_36nkefqpgns0fi99mmslq2ls1m